In addition, CCL2 is known to promote chemotactic recruitment, RANKL production, and osteoclast activity in response to inflammatory cytokine stimuli [30], confirming its role in osteoimmunological alterations leading to bone erosion in OM. The gene discussed is TNFSF11; the disease is ocular melanoma.